TKC Corporation
Notice of Share Buyback and Cancellation | July 2024
Takeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock on July 10, 2024, at approximately 2.8 billion yen. The acquired shares are scheduled to be canceled on the same day, July 31, 2024.
Key Figures
- Number of shares acquired: 791,100 shares
- Acquisition price: 3,545 yen per share
- Total purchase amount: 2,804,449,500 yen
AI要約
Overview of Share Buyback and Cancellation
Takeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock on July 10, 2024, for approximately 2.8 billion yen. The shares were acquired through the Tokyo Stock Exchange’s off-market buyback trading system (ToSTNeT-3), and are scheduled to be canceled on July 31, 2024. This will reduce the number of issued shares, aiming to enhance shareholder value.
Future Outlook and Impact on Shareholders
This share buyback and cancellation was conducted as part of shareholder return measures, likely to suppress share dilution and improve per-share value. The total purchase amount is within a limit of 3,190,500,000 yen, with ongoing expectations for continued improvements in capital efficiency and shareholder returns.
Takeda Pharmaceutical Company Limited
Company overview · Stock price · Financial data · All IR
